Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy

<p><strong>Introduction:</strong> Hypertrophic cardiomyopathy (HCM) is a leading cause of lethal arrhythmias in the young. Although the arrhythmic substrate has been hypothesised to be amenable to late Na+ block with ranolazine, the specific mechanisms are not fully understood. The...

Descrición completa

Detalles Bibliográficos
Main Authors:	Coleman, JA, Doste, R, Beltrami, M, Argirò, A, Coppini, R, Olivotto, I, Raman, B, Bueno Orovio, A
Formato:	Journal article
Idioma:	English
Publicado:	Frontiers Media 2024

Títulos similares

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: James A. Coleman, et al.
Publicado: (2024-04-01)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
por: Doste, R, et al.
Publicado: (2022)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
por: Coleman, J, et al.
Publicado: (2023)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
por: Palandri, C, et al.
Publicado: (2022)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
por: Passini, E, et al.
Publicado: (2015)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
por: Coleman, JA, et al.
Publicado: (2024)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Akhtar Amin, et al.
Publicado: (2018-01-01)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
por: Ji-Jian Chow, et al.
Publicado: (2024-08-01)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
por: Chow, J, et al.
Publicado: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
por: Coleman, JA, et al.
Publicado: (2023)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
por: Coleman, JA
Publicado: (2024)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
por: Safa Daghem, et al.
Publicado: (2024-01-01)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Margara, F, et al.
Publicado: (2022)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
por: Lyon, A, et al.
Publicado: (2018)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Sílvia Aguiar Rosa, et al.
Publicado: (2021-12-01)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
por: Coleman, J
Publicado: (2024)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
por: Coppini, R, et al.
Publicado: (2019)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
por: George Joy, MD, et al.
Publicado: (2024-01-01)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Francesca Margara, et al.
Publicado: (2022-12-01)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
por: Zakariye Ashkir, MD, et al.
Publicado: (2024-01-01)

Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations
por: Tatiana Saul, et al.
Publicado: (2024-12-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
por: S. M. Komissarova, et al.
Publicado: (2021-05-01)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
por: Lyon, A, et al.
Publicado: (2019)

Multiscale modelling of β-adrenergic stimulation in cardiac electromechanical function
por: Doste, R, et al.
Publicado: (2021)

Computational probabilistic quantification of pro-arrhythmic risk from scar and left-to-right heterogeneity in the human ventricles
por: Wallman, M, et al.
Publicado: (2013)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: A. G. Osiev, et al.
Publicado: (2016-02-01)

Paradoxical prolongation of QT interval during exercise in patients with HCM: Cellular mechanisms and implications for diastolic function
por: Coppini, R, et al.
Publicado: (2022)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Raffaele Coppini, MD, PhD, et al.
Publicado: (2019-11-01)

High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence
por: Martinez-Navarro, H, et al.
Publicado: (2019)

HYPERTROPHIC CARDIOMYOPATHY IN MULTIMORBIDITY
por: A. I. Lakhonina, et al.
Publicado: (2016-06-01)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
por: Josè Manuel Pioner, et al.
Publicado: (2022-04-01)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
por: Mincholé, A, et al.
Publicado: (2015)

Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter
por: Ahmad Masri, et al.
Publicado: (2022-05-01)

Hypertrophic Cardiomyopathy: A Review
por: Brian A. Houston, et al.
Publicado: (2015-01-01)

Hypertrophic Cardiomyopathy: A Review
por: Brian A. Houston, et al.
Publicado: (2014-01-01)

Hypertrophic Cardiomyopathy
por: Asra K. Butt, et al.
Publicado: (2023-03-01)

Hypertrophic cardiomyopathy
por: Sarita Gore, et al.
Publicado: (2022-01-01)

Hypertrophic Cardiomyopathy
por: Polakit Teekakirikul, MD, et al.
Publicado: (2021-09-01)

Hypertrophic cardiomyopathy
por: Murillo de Oliveira Antunes, et al.
Publicado: (2020-04-01)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
por: Lyon, A, et al.
Publicado: (2018)